We form strategic partnerships with pharmaceutical companies to develop and commercialize leading original medicines, ensuring patients get the treatment they need.
Bringing the world’s most innovative and proven medicines to Latin America
Apr 02, 2024
Acino announces new regional Leadership and hub to deliver on expanded presence and capabilities in LATAM following M8 acquisition Joel Barlan appointed as head of LATAM region
Mar 19, 2024
SERB Pharmaceuticals grants exclusive license to M8 Pharmaceuticals, an Acino company, to bring Voraxaze® (Glucarpidase) to cancer patients in Latin America
Dec 04, 2023
Acino Completes Acquisition of M8 Pharmaceuticals Significantly Expanding Presence and Capabilities In Latin America
Sep 20, 2023
Acino Significantly Expands Presence and Capabilities in Latin America Through Acquisition of M8 Pharmaceuticals
Portfolio
Fortified by a commitment to integrity and care for patients, M8 focuses on the following therapeutic areas.
Partnerships
At M8, we have a strong track record as a true partner in long-standing alliances with global pharmaceutical companies, supporting them in bringing their innovation from the regulatory stage through full commercialization.
